CRISPR Therapeutics CRSP Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Product | |||||
| Collaboration Revenue | $0-100% | $35M-90.5% | $370M+84,762% | $436K-100.0% | |
| Grant | $3.51M+51.7% | $2.31M+91.9% | $1.21M+58.3% | $762K-59.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does CRISPR Therapeutics break its business down?
- CRISPR Therapeutics (CRSP) reports revenue by product across 2 parts — Collaboration Revenue and Grant. Each is extracted from the segment footnotes and tracked over time.
- Where does CRISPR Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in CRISPR Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
